Demystifying Evidence for Antiplatelet De-escalation in ASCVD
Minneapolis Heart Institute Foundation via YouTube
MIT Sloan: Lead AI Adoption Across Your Organization — Not Just Pilot It
Google, IBM & Meta Certificates — 40% Off for a Limited Time
Overview
Google, IBM & Meta Certificates — All 10,000+ Courses at 40% Off
One annual plan covers every course and certificate on Coursera. 40% off for a limited time.
Get Full Access
Explore the complex topic of antiplatelet de-escalation strategies for atherosclerotic cardiovascular disease (ASCVD) in this 49-minute Cardiovascular Grand Rounds presentation by Matt Lillyblad, PharmD, BCCCP, BCCP from the Minneapolis Heart Institute Foundation®. Learn about the current evidence base, clinical considerations, and practical approaches to antiplatelet therapy modification in patients with established cardiovascular disease. Understand when and how to safely transition patients between different antiplatelet regimens based on their risk profiles, comorbidities, and clinical presentation.
Syllabus
Demystifying Evidence for Antiplatelet De-escalation in ASCVD | Matt Lillyblad, PharmD, BCCCP, BCCP
Taught by
Minneapolis Heart Institute Foundation